- Home
- NUW vs SMTI Comparison
NUW vs SMTI Comparison
Compare NUW & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUW
- SMTI
- Stock Information
- Founded
- NUW 2008
- SMTI 1982
- Country
- NUW United States
- SMTI United States
- Employees
- NUW N/A
- SMTI N/A
- Industry
- NUW Investment Managers
- SMTI Medical/Dental Instruments
- Sector
- NUW Finance
- SMTI Health Care
- Exchange
- NUW Nasdaq
- SMTI Nasdaq
- Market Cap
- NUW 242.2M
- SMTI 288.2M
- IPO Year
- NUW N/A
- SMTI N/A
- Fundamental
- Price
- NUW $13.59
- SMTI $32.47
- Analyst Decision
- NUW
- SMTI Strong Buy
- Analyst Count
- NUW 0
- SMTI 2
- Target Price
- NUW N/A
- SMTI $47.00
- AVG Volume (30 Days)
- NUW 45.3K
- SMTI 27.9K
- Earning Date
- NUW 01-01-0001
- SMTI 11-12-2024
- Dividend Yield
- NUW 3.66%
- SMTI N/A
- EPS Growth
- NUW N/A
- SMTI N/A
- EPS
- NUW N/A
- SMTI N/A
- Revenue
- NUW N/A
- SMTI $78,056,873.00
- Revenue This Year
- NUW N/A
- SMTI $30.48
- Revenue Next Year
- NUW N/A
- SMTI $24.07
- P/E Ratio
- NUW N/A
- SMTI N/A
- Revenue Growth
- NUW N/A
- SMTI 24.66
- 52 Week Low
- NUW $12.45
- SMTI $26.00
- 52 Week High
- NUW $14.44
- SMTI $40.75
- Technical
- Relative Strength Index (RSI)
- NUW 44.27
- SMTI 41.50
- Support Level
- NUW $13.64
- SMTI $31.33
- Resistance Level
- NUW $13.71
- SMTI $35.00
- Average True Range (ATR)
- NUW 0.11
- SMTI 1.39
- MACD
- NUW 0.02
- SMTI -0.09
- Stochastic Oscillator
- NUW 64.71
- SMTI 30.00
About NUW Nuveen AMT-Free Municipal Value Fund
Nuveen AMT-Free Municipal Value Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations. The fund predominantly invests in long-term municipal bonds, corporate bonds, short-term municipal bonds, and other assets.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.